Telemark Asset Management’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-600,000
Closed -$5.93M 62
2021
Q3
$5.93M Hold
600,000
0.43% 52
2021
Q2
$5.89M Hold
600,000
0.47% 58
2021
Q1
$5.81M Buy
+600,000
New +$5.89M 0.49% 57

Other funds holding GRNA

Telemark Asset Management's GRNA Position: Q4 2021 in Review

Telemark Asset Management sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q4 2021, closing a stake of 600,000 shares — an estimated $5.93M sold.

Telemark Asset Management first reported a position in GRNA in Q1 2021 and held it in 3 quarters. The position peaked at $5.93M in Q3 2021. 68 funds tracked by Wall St. Rank hold GRNA as of Q4 2021.

  • Telemark Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q4 2021 after selling out during the quarter.
  • Telemark Asset Management sold 600,000 GreenLight Biosciences Holdings, PBC Common Stock shares in Q4 2021, an estimated $5.93M.
  • Telemark Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 3 quarters.
  • Telemark Asset Management's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $5.93M in Q3 2021.
  • 68 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q4 2021.

Based on Telemark Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.